Connect
MJA
MJA

Erratum

Med J Aust 2023; 218 (11): 544-544. || doi: 10.5694/mja2.51975
Published online: 19 June 2023
This erratum corrects the following: The Queensland IMplementation of PRecision Oncology in brEast cancer (Q‐IMPROvE) pilot study

McCart Reed AE, Hollway G; Q‐IMPROvE study group; Lakhani S. The Queensland IMplementation of PRecision Oncology in brEast cancer (Q‐IMPROvE) pilot study. Med J Aust 2023; 218: 374–375. https://doi.org/10.5694/mja2.51900.

In the fourth paragraph, “Further, one patient had a DPYD variant (rs55886062) that predicts a cardiotoxic response to 5‐fluorouracil‐based chemotherapy” should read “Further, one patient had a DPYD variant (rs55886062) that predicts a toxic response to 5‐fluorouracil‐based chemotherapy.”

 




Correspondence: 

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.